More than one-third of adults in the United States have metabolic syndrome, a cluster of conditions that significantly raise ...

Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...

UCLA researchers have developed a deep-learning framework that teaches itself quickly to automatically analyze and diagnose ...

The trial's primary goal is to assess the efficacy, safety and tolerability of daily oral doses of SCI-110 in adults aged 18 ...

attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy in a clinical trial. The drug, called amycretin and codenamed ...